According to the invention, there is provided a complex of a pharmaceutical compound selected from the group consisting of opioids, hormones, anaethetics and chemotherapeutic agents comprising the reaction product of: (a) one or more phosphate derivatives of one or more opioids, steroid hormones, thyroid hormones, anaesthetics or chemotherapeutic agents having a phenolic, primary alcohol, secondary alcohol or tertiary hydroxyl group; and (b) a complexing agent selected from the group comprising amphoteric surfactants, cationic surfactants, amino acids having nitrogen functional groups and proteins rich in these amino acids.
3-deoxy-11,17-oxygenated-androstanes
申请人:UPJOHN CO
公开号:US02881188A1
公开(公告)日:1959-04-07
11-oxygenated 17alpha, 21-dihydroxyallopregnan-20-one and esters thereof